Hemodilution increases cerebral blood flow in acute ischemic stroke

Area of Science:

• Neurology
• Vascular Medicine
• Medical Imaging

Background:

• Acute ischemic stroke is characterized by reduced cerebral blood flow (CBF).
• Focal hypoperfusion in critical brain areas is a hallmark of stroke, impacting tissue viability.
• Hemodilution is a therapeutic strategy aimed at improving blood flow properties.

Purpose of the Study:

• To evaluate the effect of hemodilution on cerebral blood flow in acute ischemic stroke patients.
• To assess regional changes in cerebral blood flow within hypoperfused areas following hemodilution.

Main Methods:

• Cerebral blood flow was measured using xenon-133 inhalation and emission tomography.
• 10 selected acute ischemic stroke patients (onset < 48 hours) with focal hypoperfusion were included.
• Hemodilution involved controlled blood withdrawal and dextran 40 replacement based on hematocrit levels.

Main Results:

• Mean hematocrit decreased by 16% (46% to 39%), with statistical significance (p < 0.001).
• Overall cerebral blood flow increased by an average of 20.9% across both hemispheres (p < 0.001).
• Regional cerebral blood flow in ischemic areas increased by 21.4% (p < 0.001), with redistribution observed in some patients.

Conclusions:

• Hemodilution therapy effectively increases cerebral blood flow in patients experiencing acute ischemic stroke.
• The observed increase in regional cerebral blood flow suggests potential for improved oxygen delivery to ischemic brain tissue.
• Findings support hemodilution as a viable intervention for enhancing perfusion in stroke-affected areas.